Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots.

The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government ...

The company also recently received FDA approval for its new Covid-19 vaccine mNEXSPIKE. To mitigate the price decline and loss of revenue, the company has shifted to focus on cost efficiencies, as ...

A new Moderna vaccine, called mNexspike, was tested against Moderna’s original Covid vaccine in a study of about 11,000 people and found to be slightly more effective.

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots.